Why it matters: Senate Memorial 12 was recently signed into law in New Mexico, requesting research on the efficacy of using psilocybin mushrooms for therapeutic treatments.
What they are saying: The proposal aims to address the high rates of mental illness, suicides, drug overdoses, and alcohol-related deaths in New Mexico by exploring the potential medical benefits of psilocybin.
The big picture: Psilocybin legislation is gaining traction in other states, as well as internationally, with increasing recognition of the therapeutic value of psychedelic substances.
What to watch: Keep an eye on the results of the research conducted under SM-12, as well as the progress of psilocybin legalization efforts in other states and countries.
My take: The growing interest in exploring the therapeutic potential of psilocybin mushrooms highlights a shift in attitudes towards psychedelic substances and their potential medical benefits. It will be important to monitor the outcomes of these research efforts in order to better understand the role of psilocybin in treating mental health issues.
